These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31204247)

  • 1. Validation of biochemical scores for liver steatosis before and 1 year after sleeve gastrectomy.
    Ruiz-Tovar J; Zubiaga L
    Surg Obes Relat Dis; 2019 Sep; 15(9):1447-1453. PubMed ID: 31204247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of nonalcoholic fatty liver disease in morbidly obese patients after sleeve gastrectomy: association of ultrasonographic findings with lipid profile and liver enzymes.
    Ruiz-Tovar J; Alsina ME; Alpera MR;
    Acta Chir Belg; 2017 Dec; 117(6):363-369. PubMed ID: 28585487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of Liver Steatosis Quantified by MR Imaging and MR Spectroscopy, in Morbidly Obese Patients Undergoing Sleeve Gastrectomy: Short-Term Outcomes.
    Alsina ME; Ruiz-Tovar J; Bernabeu A
    Obes Surg; 2017 Jul; 27(7):1724-1728. PubMed ID: 27885531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology.
    Calvo N; Beltrán-Debón R; Rodríguez-Gallego E; Hernández-Aguilera A; Guirro M; Mariné-Casadó R; Millá L; Alegret JM; Sabench F; del Castillo D; Vinaixa M; Rodríguez MÀ; Correig X; García-Álvarez R; Menendez JA; Camps J; Joven J
    World J Gastroenterol; 2015 Jun; 21(24):7529-44. PubMed ID: 26140000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SCCA-IgM as a Potential Biomarker of Non-Alcoholic Fatty Liver Disease in Patients with Obesity, Prediabetes and Diabetes Undergoing Sleeve Gastrectomy.
    Bettini S; Bordigato E; Milan G; Dal Pra' C; Favaretto F; Belligoli A; Sanna M; Serra R; Foletto M; Prevedello L; Busetto L; Fassina G; Vettor R; Fabris R
    Obes Facts; 2019; 12(3):291-306. PubMed ID: 31104052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of Laparoscopic Sleeve Gastrectomy on Nonalcoholic Fatty Liver Disease.
    Batman B; Altun H; Simsek B; Aslan E; Namli Koc S
    Surg Laparosc Endosc Percutan Tech; 2019 Dec; 29(6):509-512. PubMed ID: 31107849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Pilot Study of Serum Sphingomyelin Dynamics in Subjects with Severe Obesity and Non-alcoholic Steatohepatitis after Sleeve Gastrectomy.
    Ramos-Molina B; Castellano-Castillo D; Pastor O; Ocaña-Wilhelmi L; Fernández-García D; Romero-Gómez M; Cardona F; Tinahones FJ
    Obes Surg; 2019 Mar; 29(3):983-989. PubMed ID: 30488259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between Lipocalin-2 level and hepatic steatosis in obese patients with NAFLD after bariatric surgery.
    Chen J; Lei S; Huang Y; Zha X; Gu L; Zhou D; Li J; Liu F; Li N; Du L; Huang X; Lin Z; Bu L; Qu S
    Lipids Health Dis; 2022 Jan; 21(1):10. PubMed ID: 35034646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of surgically induced weight loss on nonalcoholic fatty liver disease in morbidly obese Indians: "NASHOST" prospective observational trial.
    Praveen Raj P; Gomes RM; Kumar S; Senthilnathan P; Karthikeyan P; Shankar A; Palanivelu C
    Surg Obes Relat Dis; 2015; 11(6):1315-22. PubMed ID: 26003897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of bariatric surgery on nonalcoholic fatty liver disease as measured using non-invasive tests.
    Netanel C; Goitein D; Rubin M; Kleinbaum Y; Katsherginsky S; Hermon H; Tsaraf K; Tachlytski I; Herman A; Safran M; Ben-Ari Z
    Am J Surg; 2021 Jul; 222(1):214-219. PubMed ID: 33309037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-invasive Evaluation of NAFLD with Indocyanine Green Clearance Test: a Preliminary Study in Morbidly Obese Patients Undergoing Bariatric Surgery.
    Danin PE; Anty R; Patouraux S; Raucoules-Aimé M; Gugenheim J; Tran A; Gual P; Iannelli A
    Obes Surg; 2018 Mar; 28(3):735-742. PubMed ID: 28875438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients.
    Garg H; Aggarwal S; Shalimar ; Yadav R; Datta Gupta S; Agarwal L; Agarwal S
    Surg Obes Relat Dis; 2018 Jan; 14(1):81-91. PubMed ID: 29126863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NONALCOHOLIC FATTY LIVER DISEASE AND ITS COMPLICATIONS--ASSESSING THE POPULATION AT RISK. A SMALL SERIES REPORT AND LITERATURE REVIEW.
    Livadariu R; Timofte D; Danilă R; Ionescu L; Diaconu C; Soroceanu P; Sângeap AM; Drug VL; Trifan A
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):346-52. PubMed ID: 26204635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal Comparison of the Effect of Gastric Bypass to Sleeve Gastrectomy on Liver Function in a Bariatric Cohort: Tehran Obesity Treatment Study (TOTS).
    Motamedi MAK; Khalaj A; Mahdavi M; Valizadeh M; Hosseinpanah F; Barzin M
    Obes Surg; 2019 Feb; 29(2):511-518. PubMed ID: 30298459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laparoscopic Sleeve Gastrectomy Resolves NAFLD: Another Formal Indication for Bariatric Surgery?
    Esquivel CM; Garcia M; Armando L; Ortiz G; Lascano FM; Foscarini JM
    Obes Surg; 2018 Dec; 28(12):4022-4033. PubMed ID: 30121855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effects of sleeve gastrectomy for non-alcoholic steatohepatitis estimated by paired liver biopsy in morbidly obese Japanese patients.
    Murakami E; Nakahara T; Hiramatsu A; Morio K; Fujino H; Yamauchi M; Kawaoka T; Tsuge M; Imamura M; Aikata H; Fudeyasu K; Nakashima Y; Iwaki D; Jodai D; Ohigashi T; Nishimura Y; Minamoto Y; Nagao A; Yoneda M; Saeki Y; Tanabe K; Ohdan H; Chayama K
    Medicine (Baltimore); 2021 Jul; 100(26):e26436. PubMed ID: 34190166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimally Invasive Sleeve Gastrectomy as a Surgical Treatment for Nonalcoholic Fatty Liver Disease in Liver Transplant Recipients.
    Ayloo S; Guss C; Pentakota SR; Hanna J; Molinari M
    Transplant Proc; 2020; 52(1):276-283. PubMed ID: 31889539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Laparoscopic Sleeve Gastrectomy on the Course of Non-Alcoholic Fatty Liver Disease in Morbidly Obese Patients during One Year of Follow Up.
    Głuszyńska P; Łukaszewicz A; Diemieszczyk I; Chilmończyk J; Reszeć J; Citko A; Szczerbiński Ł; Krętowski A; Razak Hady H
    J Clin Med; 2023 Jun; 12(12):. PubMed ID: 37373815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating feasibility and accuracy of non-invasive tests for nonalcoholic fatty liver disease in severe and morbid obesity.
    Ooi GJ; Earnest A; Kemp WW; Burton PR; Laurie C; Majeed A; Johnson N; McLean C; Roberts SK; Brown WA
    Int J Obes (Lond); 2018 Nov; 42(11):1900-1911. PubMed ID: 29463916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bariatric surgery during the evolution of fatty liver-A randomized clinical trial comparing gastric bypass and sleeve gastrectomy based on transient elastography.
    de Barros F; Fonseca ABM
    Clin Obes; 2020 Dec; 10(6):e12393. PubMed ID: 32885600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.